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Objectives: Randall initially described calcified subepithelial papillary plaques, which he 
hypothesized as nidi for kidney stone formation. The discovery of calcifying 
nanoparticles (CNP) in many calcifying processes of human tissues has raised another 
hypothesis about their possible involvement in urinary stone formation. This research is 
the first attempt to investigate the potential association of these two hypotheses. 
Methods: We collected renal papilla and blood samples from 17 human patients who had 
undergone laparoscopic nephrectomy due to neoplasia. Immunohistochemical staining 
(IHS) was applied on the tissue samples using monoclonal antibody 8D10 (mAb) against 
CNP.  Homogenized papillary tissues and serum samples were cultured for CNP. 
Scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS) 
analysis were performed on fixed papillary samples.   
Results: Randall’s plaques were visible on gross inspection in 11 out of 17 collected 
samples. IHS was positive for CNP antigen in 8 of these 11 visually positive samples, but 
in only 1 of the remaining 6 samples. SEM revealed spherical apatite formations in 14 
samples, all of which had calcium and phosphate peaks detected by EDS analysis.  
Conclusion. From this study, there was some evidence of a link between the presence of 
Randall’s plaques and the detection of CNP, also referred to as nanobacteria. Although 
causality was not demonstrated, these results suggest that further studies with negative 
control samples should be made to explore the etiology of Randall’s plaque formation, 
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Seventy years ago, Randall performed a detailed examination of the papillae of more than 
1,000 cadaveric renal units, and demonstrated that interstitial crystals located at, or 
adjacent to, the papillary tip were common in stone formers [1]. He found that these 
crystals were composed not of calcium oxalate (CaOx), the most common solid phase 
found in patients with nephrolithiasis, but of calcium phosphate (CaP) [2], and termed 
them as plaques. He believed that the CaP crystals precipitated in the papillary 
interstitium and subsequently eroded into the urinary space, serving as a nucleation 
surface for CaOx [2]. In vitro, CaP phases efficiently nucleate CaOx crystallization [3], 
so that one can easily conjecture that common CaOx stones begin on plaques. Recently, 
Matlaga et al have analyzed Randall’s plaques and confirmed that they are formed of 
spherical, CaP particles [4]. Coe et al have also observed Randall’s plaques with TEM 
and shown CaP deposits appearing as single spheres with a multilaminated internal 
morphology (Fig. 1 A and B). According to Merck Manual, all pathological calcifications 
contain snowball-like CaP spheres 200 nm in size [5]. However, the pathogenesis and 
identity of those spherical formations have remained elusive.   
Structures similar to snowballs described by Merck Manual were discovered over a 
decade ago in blood and blood products [6]. These structures, known as nanobacteria, or 
CNP, were detected in numerous pathological calcification-related diseases [7-10]. The  
CNP are membrane-enclosed cell-like calcified vesicles [6], and they are 
morphologically and in mineral composition very similar to spherical bodies observed in 
Randall’s plaques (Fig. 1). CNP contain no detectable genomic DNA or RNA, but yet 
appear capable of self propagation [11]. Due to lack of their genomic definition, CNP are 
controversial agents as prions were, and critics have proposed different hypotheses to 
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explain them as protein precipitates or crystal formation [12]. Although we know that 
CNP cause specific infection [13], and were detected in calcified tissue samples, general 
debate over their existence continues. Methods to detect CNP in biological samples 
include immuno-detection techniques using anti-CNP mAbs, specific culture techniques 
and electron microscopy [14]. With these methodologies, some important features of 
CNP and their triggering effect on nephrolithiasis have been suggested. These features 
include: A) CNP consist of tiny spheres (80-200nm) resembling “cells”. They appear to 
precipitate apatite from their surrounding media forming apatite-protein complexes. 
Immunoelectronmicroscopy reveals protein antigens in close proximity to precipitated 
apatite, suggesting a novel form of protein-associated mineralization [15]. B) CNP 
mineralization starts as extremely small apatite crystals and forms on the exterior 
membrane of 80-200nm diameter CNP followed by a growing shell or an enclosing 
sphere of apatite which may reach a diameter of one to several micrometers [16]. C) 14% 
of healthy adults in Scandinavia have anti-CNP antibodies [17]. In comparison, a high 
fraction (75%) of patient groups with kidney diseases has CNP antigen in blood [18]. D) 
CNP form apatite units/shells in vitro, morphologically and chemically similar to those in 
the core of kidney stones, (Fig. 2) [19]. E) CNP are renotropic [20]. F) CNP cause kidney 
stone formation when injected into rats [21]. G) CNP have been detected in different 
types of kidney stones [19]. H) In vitro, destruction of the calcified apatite shell of CNP 
with EDTA-chelation reveals numerous 80 to 100nm diameter membranous cells [16] 
similar to those observed in Randall plaques by other research groups [4]. I) TEM study 
of renal plaques shows 1-5 μm apatite spheres laminated with mineral and organic 
molecules [4], similar to the structure of CNP (Fig.1) [6].  
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In this study, our aim was to investigate the association between the presence of CaP 
spheres found in Randall’s plaques and detection of CNP. Such an association would be a 
basis for a formal hypothesis that can be discussed, and used to drive further studies in 
larger patient groups.  
 
2. Materials and methods 
 
2.1. Subjects  
Renal papillae were dissected from 17 patients who had undergone laparoscopic 
nephrectomy due to neoplasia (Renal cell carcinoma, n=9; Transitional cell carcinoma, 
n=4; Other malignancies; n=4). Presence or absence of Randall’s plaques was evaluated 
on gross inspection of immediately extracted and bivalved kidneys. Intact papillae were 
harvested well away from the tumor, and were prepared for the analyses with IHS, SEM, 
EDS and CNP culture. Blood was drawn in the fasting state from patients immediately 
before and after surgery. The serum was used for CNP culture, and enzyme-linked 
immunosorbent assay (ELISA) to detect CNP antigen and antibody. Bladder urine 
samples of patients were collected for routine bacterial culture. The study was approved 
by the UCSF Committee on Human Research and every patient was given detailed 
information regarding the procedures involved in this research and signed an informed 
consent prior to any manipulation. 
 
2.2. Tissue preparation for analysis  
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Papillary specimens of 17 patients for IHS and SEM experiments were immediately 
immersed in 4% paraformaldehyde and refrigerated overnight. IHS samples were paraffin 
embedded and prepared for IHS as described earlier [22]. SEM samples were dehydrated 
and gold-coated as described previously [6]. The tissue samples for CNP cultures were 
immediately placed into 2ml of sterile phosphate buffered saline (PBS), pH 7.4, 
homogenized for 30-seconds, four times, with 30-second cooling intervals on ice using 
conventional, 5ml glass tissue-grinders. Homogenized tissue was centrifuged at 2500g for 
15-minutes. The supernatant was separated and sterile-filtered through 0.22μm pore size, 
non-protein binding filters (Millipore) into sterile non-adhesive tubes and stored at -70oC 
until processed for culture as described below.  
 
2.3. IHS analysis of papillary samples 
Paraffin-embedded papillary samples were cut into 5µm sections, deparaffinized and 
rehydrated [22]. Each tissue section was demineralized in 250mM sodium citrate for 24 
hours at +4oC, to retrieve apatite crystal-covered epitopes prior to IHS. After washing in 
water, endogenous peroxidase was blocked with 1% H2O2 in methanol for 30min. Slides 
were then rinsed in PBS before staining with a catalyzed signal amplification IHS (Dako, 
Carpinteria, CA, USA). Anti-CNP mAb, 8D10 (Nanobac Oy, Kuopio, Finland), was used 
as primary antibody which is recommended by the manufacturer for detection of CNP in 
formalin-fixed paraffin embedded tissue sections. All slides were counterstained with 
hematoxylin, and mounted with glycerol. Negative control sections went through the 
same staining process, except that the primary mAb step was omitted.  
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2.4. CNP cultures from serum and tissue samples 
Patient serum samples, and homogenized tissue supernatant samples were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco Lab Inc., Grand Island, NY) 
under mammalian cell culture conditions (37oC, 5-10% CO2, 90-95 % humidity) for 4 
weeks. Patient sera were cultured at 10% final concentration, and tissue homogenates 
were cultured both with and without fetal bovine serum (FBS) supplementation (as a 
growth factor) which was previously tested for CNP and evaluated as CNP negative 
(Atlanta Biologicals, GA) as described earlier [14]. The pellets from the homogenized 
tissue were incubated with 30mM EDTA for 1-hour at room temperature for 
decalcification, and release of enclosed CNP from the apatite units, diluted 1:10 in 
DMEM, and cultured as described above. Each sample was filtered through 0.22μm pore-
sized filters before culturing in order to eliminate potential conventional-bacterial 
contamination in a Biosafety level-2 facility. Cultures were checked for gross bacterial 
contamination by microscopy and macroscopic observation of turbidity and color change 
of the medium from the third day of incubation. Control culture plates, containing only 
culture media, were incubated in parallel with the test plates to determine whether 
spontaneous crystallization or precipitation can occur. Every week, the culture plates 
were inspected by phase contrast microscopy (Nikon Eclipse TE 2000-U) for CNP 
propagation. Positive identification of CNP involved typical slow propagation and optical 
properties, negative signal with Hoechst 33258 dye, and positive signal with indirect 
immunofluorescence staining (IIFS) [11]. Serum and tissue homogenate cultures for CNP 
were rated (-) = no growth in four weeks, (+) = growth in four weeks, (++) = growth in 
three weeks, (+++) = growth in two weeks, and (++++) = growth in one week of 
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incubation. All culture samples were harvested with 14000g centrifugation for 30 min at 
4oC after 30 days of incubation. The pellets were spread on glass slides for IIFS, heat 
fixed and double-stained using CNP surface-antigen-specific mAb 8D10, followed by 
Alexa Fluor 488 goat-anti-mouse IgG secondary antibody [14]. In addition, Hoechst stain 
was used to detect conventional bacterial contamination. As a positive control for 
Hoechst, E. coli (nonpathogenic strain HB101) was used. Fluorescence photographs were 
taken using an Olympus BX60F5 microscope coupled to a Nikon digital camera DXM 
1200F.  
 
2.5. SEM and EDS microanalysis  
Papillary samples 2-4 mm in block size were analyzed both for morphology and chemical 
composition using JEOL 6340 Field Emission SEM with attached IXRF EDS analyzer 
[6]. Each sample was divided into 4 mapping areas and each area was scanned for small, 
100-500nm spherical forms, and calcium-rich or phosphate-rich particles. Cultured CNP 
and one oxalate kidney stone (provided by University of Kuopio Hospital/Finland) 
sample were prepared for SEM analysis using the same preparation technique for tissue 
samples. In EDS analyses, hydroxyapatite (Sigma, H-0252, St. Louis, MO) was used as a 
reference. SEM results were rated as (-) = no CNP observed; otherwise as the number of 
mapped areas in which CNP was seen (+ to ++++). 
 
2.6. Biochemical Assays 
The commercially available ELISA kits for detecting anti-CNP IgG and CNP-antigen; 
Nano-Sero IgG ELISA , and Nanocapture ELISA (Nanobac Oy, Finland) respectively 
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were used. All measurements were run in duplicates. Nano-Sero IgG ELISA is used to 
detect exposure to CNP. Antibody formation occurs after exposure to these agents [13]. 
Nanocapture ELISA measures quantitatively CNP antigen from a 50μl serum sample. 
The detection antibody recognizes CaP-binding protein-antigen on CNP in a special CaP 
complex conformation (ELISA kit inserts). There was not enough serum of subject #17 
and therefore ELISA tests were not performed on this sample. For Nanocapture ELISA, a 
ratings were  (-): < 3.5 units/ml; (+): 3.5-11.0 units/ml; (++):  11.0-50.0 units/ml; (+++):  
50.0-150 units/ml; and (++++): > 150 units/ml. For Nano-sero ELISA, ratings were (-): < 
0.1 units/ml; (+):  0.1 - 0.4 units/ml; (++):  0.4 - 0.5 units/ml; (+++):  0.5 - 0.7 units/ml; 
and (++++): > 0.7 units/ml. 
 
2.7. Statistical analysis 
Descriptive results of the various analytic techniques are displayed in terms of ratings in 
Table 2. Association between SEM findings and CNP growth ratings in tissue cultures 
was quantified in terms of contingency table analysis (Fisher Exact Test) with ratings 
collapsed to either 0 [rating = (-)] or 1 [rating = (+) – (++++)]. A similar analysis was 





Eleven male and 6 female patients were enrolled in our study, with a mean age of 65.5 
and 78 years, respectively. Visually, Randall’s plaques were observed on the papillae of 
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11 patients, with no sexual preponderance. No correlation was found between the 
observation of Randall’s plaques and the patients’ tumor types (Table 1). Urine cultures 
for conventional bacteria were negative in 12 patients, showed mild growth of genital 
flora in 3 patients and were positive for enterococcus species in 2 patients. 
 
3.2. IHS 
The results of papillae analyzed using IHS is summarized in Table 2. Nine out of 17 
tissue samples stained positive for CNP antigen. Positive staining results, as a brown-
colored precipitate at the antigen site, are shown in Fig.3 A, B and F. Negative controls 
that were stained with the same technique by omitting the mAb, did not show any non-
specific signal (Fig 3 E). Eight papillary samples were negative with IHS (Figs.3 C and 
D).  
 
3.3. CNP cultures of serum samples and tissue homogenates 
All serum samples and 13 of 17 papillary tissue homogenates and tissue pellets contained 
propagating CNP at different growth rates (Table 2). The differences observed in the 
propagation rate may reflect existence of CNP in different concentrations. Three serum 
samples were already positive within three days of culture. All propagation-positive 
samples stained positive with IIFS using anti-CNP mAb, 8D10 (Fig. 4A), but stained 
negative with the Hoechst (Fig. 4B), indicating no bacterial contamination in cultures. 
The positive control for Hoechst dye, E. coli, was stained blue (Fig. 4C), but no 
nonspecific-signal was detected with 8D10 (Fig. 4D). SEM of cultured CNP showed 
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typical morphology of CNP (Fig. 5A), as described earlier [11]. In negative controls, no 
CNP growth, no mineralization or protein precipitation was observed.  
 
3.4. SEM Analysis 
Fourteen of 17 tissue samples contained CNP-like particles in various sizes (Fig. 5 B-D 
and Fig 6B). The tissue samples without visible, macroscopic plaques had fewer spherical 
apatite formations compared with samples with visible plaques (Fig. 7).  The tissue cells 
with those apatite particles looked more deformed with fibrous formation (Figs. 5 C, D 
and 7F) whereas the negative tissue cells looked more intact (Figs. 6A and 7G). The 
apatite spheres produced an EDS pattern (Fig. 6C) identical to the CNP EDS patterns as 
observed in our earlier studies [6, 19].  
 In SEM analysis, oxalate kidney stone had spherical units in the core, similar to 
cultured CNP from renal plaques (Fig. 2) with identical EDS patterns.   
 
3.5. ELISA 
Out of 16 tested serum samples, 14 were positive for CNP-antigen, and 11 were positive 
for CNP-antibody. Nano-Sero IgG, and Nanocapture ELISA test results are summarized 
at Table 2. 
 
3.6. Association between CNP and SEM detection of Randall's Plaques 
Two-by-two contingency tables for SEM (detection of spherical apatite formations on 
renal papilla) versus tissue culture growth and SEM versus ELISA-Ag concentration 
ratings are shown in Tables 3 and 4, respectively. Note that 12 of 14 positive SEM 
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samples showed CNP growth, while 1 of 3 negative samples showed growth (Table 3, P 
= 0.121, Fisher's Exact Test). On the other hand the ELISA-Ag results were 





Plaques, defined as sites of interstitial crystal deposition at or near the papillary tip, are 
found in kidneys of CaOx-stone formers (100%) and often, but less frequently, in people 
who do not form CaOx stones (43%) [23]. The nucleus of these plaques are composed of 
CaP [24]. Despite extensive basic and clinical studies on Randall’s plaques, the reason of 
CaP accumulation in the first place always remained elusive.  
The discovery of CNP encapsulated in a CaP shell, and their subsequent detection in 
several human pathologic calcification processes, raised hopes for an explanation for 
Randall’s plaques [16]. Soon after their discovery, the CNP were detected in human 
urinary stones [19, 25]. Inspired by these observations, we hypothesized that CNP might 
actually be the initiating agents in the formation of Randall’s plaques and subsequently 
the renal stones. CNP resemble the snowballs from pathological calcifications, described 
by Merck Manual “cell” size (~0.1-0.5µm). In addition, they cause rapid in situ 
precipitation of CaP from blood and other body fluids under conditions not normally 
conducive to such precipitation [6]. CNP are renotropic, as reported from rabbit 
experiments using injected radiolabelled-CNP and are eliminated from the circulation 
through urinary excretion [20]. It was also shown that translumbar, percutaneous 
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intrarenal injection of CNP into rats resulted in kidney stone formation [21]. Whether 
CNP themselves serve as the nucleus for crystal formation, or they are simply able to 
lower the activation energy barrier and thus allow precipitation and growth of crystals 
under much lower supersaturation conditions is yet to be determined.  
In this study, we investigated the presence of CNP in the Randall’s plaques of non 
stone-forming human patients. For apparent reasons, kidneys could not be obtained from 
healthy subjects to serve as negative controls. Similarly, kidneys from renal stone patients 
are normally not removed, unless complicated by severe hydronephrosis or superimposed 
pyelonephritis / pyonephrosis. All subjects in our study had their kidneys removed due to 
a renal mass. 
We observed Randall’s plaques in 65% of the extracted kidneys, and searched for CNP 
in the renal papillae through IHS, SEM and culture techniques. 72% of plaque-positive 
tissues were positive for CNP antigen in IHS. IHS was negative in 83% of plaque-
negative tissues, indicating a statistically significant association (p=0.043). Negative IHS 
result in a plaque-positive sample could be due to the fact that a section plane might not 
cut through the plaque or the plaque is lost during the processing because it is very hard 
tissue, and difficult to cut.  On the other hand, visually plaque-negative sample might 
stain positive if CNP antigen is actually present in the tissue but macroscopically 
invisible. 
SEM provides additional information regarding the presence or absence of CNP 
through the distinctive morphology of these particles (Fig. 5). SEM of papillae revealed 
CNP-like spheres in the majority of the samples, irrespective of the presence of visible 
Randall’s plaques. As with IHS, CNP morphology might not be observed in a plaque-
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positive tissue if the plaque does not pass through the tissue surface inspected under 
SEM, or be detected in a visually plaque-negative sample if plaques are too small.  
In our earlier TEM analysis of CNP shells we defined their morphology as “tree-age-
ring-like” formations of crystal and organic matter [26], a description which is almost 
identical to observations in Randall’s plaques (Fig. 1) by others [24]. We also have 
observed apatite spherical formations in the core of kidney stones independent of their 
overall chemical composition (Fig. 2), and cultured CNP from those stones [19].   
In EDS analysis, the CNP-like spheres on paplillae produced calcium and phosphate 
peaks identical to that of the CNP in previous reports. No calcium-phosphate peaks were 
detected in tissues without CNP-like spheres.  
To see if these apatite spheres are actually capable of propagating, a typical property 
of CNP of potential pathogenic importance in stone growth or formation, we cultured the 
papillary tissue extracts obtained from our patients. All but one sample grew CNP within 
4 weeks (Table 2), as identified by IFS of harvested culture pellets with the CNP-specific 
mAb. We cultured patient serum samples obtained before and after surgical 
manipulation, all of which turned positive within 4 weeks (Table 2).  ELISA tests 
measuring CNP antigen (15/16) and antibody (11/16) in patient blood are also strongly 
correlated with culture results.  
To a great extent, our studies accord with and confirm much of Randall’s pioneering 
work. The plaque is interstitial and composed of apatite. What we add, here, is that many 
of the apatite formations are culturable and stainable with CNP-specific mAb. Therefore 
one conclusion could be that Randall’s plaques contain CNP. Where do these CNP come 
from? Stoller et al suggested vascular origin of Randall’s plaques [27]. We have detected 
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CNPs in blood [6]. The described elimination route via kidneys into urine may be a way 
for CNP to form an infectious foci or agglomeration in the kidneys. Infectious foci may 
form the Randall’s plaque [26]. Interestingly, CNP have been also detected in 
calcifications of atherosclerosis [8]. In both these cases, as pathological calcification in 
general, CaP particles 200 nm in size have been observed. Thus, CNPs could be the long 
looked for 200 nm CaP snowballs present in pathological calcification. 
  The finding of CNP in Randall’s plaque needs to be confirmed with a prospective 
research design including a larger patient population and negative controls. We have 
developed diagnostic tools for this unique agent, and also found that CNP are susceptible 
to certain antibiotics [28].  If supported by further work, this hypothesis may lead to 
treatment designed to disable the CNP, prevent or control the precipitation of apatite, and 
treat the formation of kidney stones as a consequence of an infection. 
 
5. Conclusion 
With this small and retrospective study, we found some evidence of a link between the 
presence of Randall’s plaques and the detection of CNP, also referred to as nanobacteria. 
These results suggest that further studies with negative control samples should be made 
to explore the etiology of Randall’s plaque formation, thus leading to a better 
understanding of the pathogenesis of urolithiasis. 
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Titles and legends for figures 
 
Figure 1. Morphological similarities of published TEM images of spherical, apatite 
containing formations in renal papilla (A and B), and CNP (C and D). Magnifications: A, 
20,000X; B 30,000X; C and D, bars 200nm. 
Reprinted from; A:  Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 
115:2598-2608, 2005 [24] with permission from American Urological Association. B: 
Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall's plaques in the 
pathogenesis of calcium stones. J Urol. 177:31-38, 2007 [4] with permission from 
American Urological Association. C: Kajander EO, Ciftcioglu N. Nanobacteria: an 
alternative mechanism for pathogenic intra- and extracellular calcification and stone 
formation. Proc Natl Acad Sci U S A. 95:8274-8279, 1998 [6] with permission from 
copyright 1998 National Academy of Sciences USA. D: Kajander EO, Ciftcioglu N, Aho 
K, Garcia-Cuerpo E. Characteristics of nanobacteria and their possible role in stone 
formation. Urol Res. 31:47-54, 2003 [26] with kind permission from Springer Science 
and Business Media. 
 
Figure 2. SEM images of apatite spheres in various sizes in the core of an oxalate kidney 
stone (A), apatite formations in the CNP culture (B). Bars= A; 1μm, B; 10μm. 
 
Figure 3. Immunohistochemical (IHS) staining of paraffin embedded renal tissue by 
using anti-CNP monoclonal antibody. Brown color shown by black arrows indicates 
positive signal (existence of CNP antigen) in the tissue. The images shown at A (100X) 
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and B (200X) are from renal plaque positive, IHS-positive tissue. C (100X) and D (400X) 
are from IHS-negative tissue, E and F (200X) are consecutive sections from a positive 
tissue. E is stained by omitting the monoclonal antibody, showing no positive signal 
whereas in F positively stained in one of the collecting ducts. 
 
Figure 4. Light microscopic images of double staining results of patient samples cultured 
under CNP culture conditions. (A) IIFS positive cultured patient sample recognizing the 
CNP specific monoclonal antibody when imaged with the green bandpass emission filter, 
(B) Negative results of Hoechst die the same sample (A) imaged with the blue bandpass 
emission filter. (C) IIFS negative bacterial control (nonpathogenic E. coli strain HB101) 
not recognizing the CNP specific monoclonal antibody with green bandpass emission 
filter. (D) Positive results of Hoechst die the same sample (C) imaged with the blue 
bandpass emission filter. 
 
Figure 5. SEM images of (A): cultured CNP from a serum sample, (B, C, and D): CaP 
spheres detected on renal papilla (Randall’s plaque). Bars; 2μm. 
 
Figure 6. SEM analysis of renal papilla and EDS analysis. A, Renall cells with no 
plaques. B, renal cells with plaque formations showing bumpy surface. White arrows 
show the spherical apatite formations on cells. C, EDS analysis of the one representative 
apatite sphere on the cells shown in B. 
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Figure 7. Images from Randall’s plaques. (A) Tiny calcifications at the tip of the renal 
papilla. (B) Relatively large calcified plaques. (C) A cross section through the renal 
papilla, showing sub-epithelial calcifications running deep into the renal medulla. A 
closer images of renal papilla tissue with (D) and without eye-visible plaque formations 
(E). (F) and (G) are SEM images of the tissues shown at (D) and (E) respectively. Black 
arrows show streaks of plaques on the tissue, white small arrows show the apatite spheres 
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Table 1. Association between the observation of Randall’s plaques and the patients’ 
tumor types. 
Diagnosis RP + RP - p-value (chi-square test of 
diagnosis versus RP) 
RCC 4 5 0.18 
TCC 3 1 0.92 
Other * 4 0 0.28 
RCC: Renal cell carcinoma 
TCC: Transitional cell carcinoma 
* Including oncocytoma and medullary fibroma 
Ciftcioglu et al.           Association between Randall’s plaque and calcifying nanoparticles 
 
 
Table 2. Observation of Randall’s plaques on gross inspection, and the detection of CNP 
by various methods. 




















1 - - - - - +++ + - 
2 + + +++ + - +++ + + 
3 + + +++ + ++ ++ +++ - 
4 + - +++ + + + +++ + 
5 + + + + ++ +++ ++ - 
6 + + +++ + ++ ++++ - - 
7 - - +++ + ++ +++ + - 
8 + + ++++ + + ++++ ++++ + 
9 - - ++++ + + ++++ ++++ + 
10 - + +++ + ++ ++ ++ + 
11 - - ++ + + + - + 
12 + + - - - + ++++ + 
13 - - +++ + - + ++ + 
14 + + + + + + ++ + 
15 + + - - + + ++++ +++ 
16 + - ++ + + + ++ + 
17 + - + + +++ +++ ND ND 
Positive 11 9 14 14 13 17 14 
CNP: calcifyin nano particles, IHC: Immunohistochemistry, SEM: scanning electron 
microscopy; EDS; energy dispersive X-ray spectroscopy; ND: Not done. 
11 
The serum and tissue homogenate cultures for CNP have a rating of ++++: growth in one 
week, +++: growth in two weeks, ++: growth in three weeks, +: growth in four weeks, -: 
no growth in four weeks of incubation. SEM is rated as 0 if no CNP is observed, 1 if 
CNP are seen in one of the four mapped areas, 2 if CNP are seen two of the four mapped 
area, 3 if CNP are seen three of the four mapped area, and 4 if CNP are seen in every 
scanned area at 1500X magnification. ELISA results are rated according to the ELISA kit 
manufacturer’s “1 unit” definition. 
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Table 3. Fisher’s exact analysis of SEM/EDS test results versus CNP propagation from 
the papillary tissue results. 
 











Total 4 13 17 
 
Fisher's exact =  0.121 





Table 4. Fisher’s exact analysis of SEM/EDS test results versus ELISA-Ag test results. 
 











Total 2 14 16 
 
Fisher's exact =  1.000 
1-sided Fisher's exact =  0.650 
 
    
 
